Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod

Mult Scler. 2014 Oct;20(12):1666-7. doi: 10.1177/1352458514525872. Epub 2014 Mar 6.

Authors

S Masera¹, C Chiavazza¹, A Mattioda¹, G Superti¹, E Beggiato², P Crosasso³, P Broganelli², L Pinessi¹, P Cavalla⁴

Affiliations

¹ MS Center, & I Division of Neurology, Department of Neuroscience, University of Turin & City of Health and Science of Turin University Hospital, Italy.
² Oncoematology and Dermatology Department, City of Health and Science of Turin University Hospital, Italy.
³ Hospital Pharmacy Department, City of Health and Science of Turin University Hospital, Italy.
⁴ MS Center, & I Division of Neurology, Department of Neuroscience, University of Turin & City of Health and Science of Turin University Hospital, Italy paola.cavalla@unito.it.

PMID: 24603883
DOI: 10.1177/1352458514525872

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Angioedema / chemically induced*
Angioedema / diagnosis
Angioedema / pathology
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents / adverse effects*
Knee / pathology
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Multiple Sclerosis, Relapsing-Remitting / metabolism
Propylene Glycols / adverse effects*
Receptors, Lysosphingolipid / antagonists & inhibitors
Receptors, Lysosphingolipid / metabolism
Skin / pathology
Sphingosine / adverse effects
Sphingosine / analogs & derivatives*
Sphingosine-1-Phosphate Receptors

Substances

Immunosuppressive Agents
Propylene Glycols
Receptors, Lysosphingolipid
S1PR1 protein, human
Sphingosine-1-Phosphate Receptors
Fingolimod Hydrochloride
Sphingosine